RE: another gene silencing opp with award winning GENEICE16 Jul 2019 19:26
Maybe GENEICE will be of interest to Abcam after their purchase RNS this morning:
Abcam (AIM: ABC), a global innovator in life science reagents and tools, is today pleased to announce the acquisition of the entire live cell line and lysates portfolio of EdiGene Inc, a leading company focused on developing genome editing technologies into novel therapeutics for a broad range of diseases and into creative solutions to advance drug discovery.